2026 Regeneron ISEF finalists apply biochemistry and AI to address the mental health crisis
By
Chyna Vargas
A five-star bake. Worth schmearing, sharing, saving.
Summary
This article highlights how 2026 Regeneron ISEF finalists are using biochemistry, AI, and medical research to develop solutions for the mental health crisis. Published during Mental Health Awareness Month, the piece showcases student-led scientific innovation aimed at addressing depression, anxiety, and other mental health challenges through research and technology.
Key quotes
· 3 pulledMay is Mental Health Awareness Month, a time when conversations about mental health take place across the country.
First observed in 1949, the month was created to help reduce the stigma surrounding mental health, according to the National Alliance on Mental Illness.
Read below about how several 2026 Regeneron ISEF finalists are using biochemistry, AI and medical research to help advance the con
You might also wanna read
How the CircaVent project aims to destigmatize mental health and advance brain research
An interview with Matthew Woodworth about the CircaVent project at the Wyss Institute, which aims to destigmatize mental health issues and d
wyss.harvard.edu·4d ago
A Framework for Implementing Family-Focused Mental Health Care
This Viewpoint article outlines a framework for implementing family-focused mental health care, emphasizing the need to address mental healt
doi.org·4d ago
Study Shows Youth Suicide Rates Declined After 988 National Hotline Implementation
A new study found that youth suicide rates in the United States dropped 11% below projections in the two and a half years following the 2022
nytimes.com·1mo ago
The Development of Islamic Medicine During the Golden Age of Islam
The article explores the development of Islamic medicine during the Golden Age of Islam, highlighting how physicians from Spain to Samarkand
hekint.org·1mo ago
Major Lancet Review Finds Medicinal Cannabis Ineffective for Anxiety, Depression, and PTSD
A major systematic review published in The Lancet finds that medicinal cannabis does not effectively treat anxiety, depression, or PTSD, des
Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment ha